Company overview
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing CLB with another company.
| Daily close (USD) | $10.16 |
| Market capitalization (USD) | $466,186,946.72 |
| Price / earnings (TTM) | 19.14 |
| Price / book | Not reported |
No matching rows. Clear the filter to see all records.
Read CLB's valuation metrics
Company size
Core Laboratories Inc.'s recorded market capitalization is $466,186,946.72. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
CLB's recorded P/E is 19.14: about $19.14 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.
Research Core Laboratories Inc. with Aurora
Use the snapshot above to ask a specific question about CLB. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow CLB's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.